AnchorDx
Guangzhou
About AnchorDx
Guangzhou Baseline Medical is committed to building a world-class clinical application of high-throughput sequencing and R & D platform to become the leading global provider of precision medical solutions. The company's core team has more than 20 years of senior industry experience, involved in cancer genomics, genetics and bioinformatics and other fields. Based on its core technical advantages, the Company aims at precision medicine, establishes a cooperative relationship with middle and downstream enterprises in the industry, and forms a complete industrial chain from academic research to clinical product transformation. It has also established close cooperation with many large-scale third-party inspection agencies including Illumina, Well-known domestic and foreign hospitals and research institutes to establish cooperative relations, the development of a series of independent intellectual property rights and international competitiveness of clinical testing products for patients, doctors and medical institutions to provide accurate, convenient and comprehensive services.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $68.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Feb 2021)
- Website: anchordx.com
- Phone: 400-930-0052
Industries & Categories
Biotechnology, Emergency Medicine, Pharmaceutical, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/anchordx-82173 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.